Treatment of Patients With Dual Hepatitis C and BTreatment of Patients With Dual Hepatitis C and B
Are patients with hepatitis C and B treated with pegylated interferon and an antiviral at an increased risk for developing hepatocellular carcinoma? This new study explores the connection. Gut
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Cancer & Oncology | Carcinoma | Gastroenterology | Health | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver Cancer | Study